FindMyRecallSubscribe
Class I: serious health riskTerminated

Hospira Marcaine Recall

Marcaine (bupivacaine HCl) injection, USP, 0

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Mar 26, 2014
Recall ID
D-1161-2014
Check your lot numberHow we source this data

Summary

Hospira recalled Marcaine starting Oct 18, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-1161-2014 on Mar 26, 2014. Reason: Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.

Product description

Marcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials-preservative free, packaged in 10-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1559-30.

Lot numbers, UPCs & expiration codes

Lot 25-220-DD, Exp 1JAN2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1161-2014
Classification
Class I
Status
Terminated
Recall initiated
Oct 18, 2013
FDA report date
Mar 26, 2014
Quantity
40,360 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1161-2014, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
66503
Address
275 N Field Dr
Code information
Lot 25-220-DD, Exp 1JAN2015
Postal code
60045-2579
Report date
Mar 26, 2014
Product type
Drugs
Recall number
D-1161-2014
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
40,360 vials
Termination date
Dec 18, 2015
Reason for recall
Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Marcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials-preservative free, packaged in 10-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1559-30.
Distribution pattern
Nationwide
Recall initiation date
Oct 18, 2013
Initial firm notification
Letter
Center classification date
Mar 14, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1161-2014, published Mar 26, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls